Search form

Search form

Luminex generated $53.2 million in revenue during the first quarter of 2013, up from $48.7 million during the same period last year. CEO Patrick Balthrop attributed the growth in large part to a jump in the company's assay sales.

Related Summaries

Luminex generated $57.7 million in revenue in the quarter ending March 31, up 2% from the $56.6 million generated in the same period last year. The first-quarter growth was driven by a 17% increase in the company's assay revenues.

Vermillion generated $1.6 million in revenues during the fourth quarter of 2013, an increase from $1.1 million during the same period in 2012. The company attributes this growth to increased sales from its OVA1 assay, which is used to diagnose ovarian cancer.

Jawbone hopes to strengthen its foothold in the wearable-technology space with its acquisition of BodyMedia, maker of arm bands used for weight monitoring. Financial terms of the deal were not made public, but a source said the transaction was valued at more than $100 million.

Medtronic has initiated an investigational device exemption study of its Valiant Mona LSA stent graft, with the first implantation performed by doctors in Ohio and North Carolina. The seven-participant study will evaluate the use of the device in treating aortic aneurysms in the left subclavian artery.

Philips Healthcare has sold a unit of its PET/MRI scanner to Texas Children's Hospital, which will be the first such facility in the country to deploy the technology. The installation of the scanner is part of the hospital's effort to expand its services in molecular and functional imaging.